Wolff Wiese Magana’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Wolff Wiese Magana’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,400	Closed	-$1.04K	–	830
2022 Q4	$1.04K	Hold	2,400	–	–	﹤0.01%	570
2022 Q3	$1K	Buy	2,400 +2,000	+500%	+$685	﹤0.01%	812
2022 Q2	$0	Hold	400	–	–	﹤0.01%	1004
2022 Q1	$0	Buy	+400	New	+$340	﹤0.01%	871
2021 Q4	–	Sell	-400	Closed	-$1K	–	880
2021 Q3	$1K	Hold	400	–	–	﹤0.01%	797
2021 Q2	$1K	Buy	+400	New	+$995	﹤0.01%	821

Other funds holding SIOX

JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return

CIA

Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Wolff Wiese Magana's SIOX Position: Q1 2023 in Review

Wolff Wiese Magana sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 2,400 shares — an estimated $1.04K sold.

Wolff Wiese Magana first reported a position in SIOX in Q2 2021 and held it in 6 quarters. The position peaked at $1.04K in Q4 2022. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.

Wolff Wiese Magana reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Wolff Wiese Magana sold 2,400 Sio Gene Therapies Inc. Common Stock shares in Q1 2023, an estimated $1.04K.
Wolff Wiese Magana first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2021 and held it in 6 quarters.
Wolff Wiese Magana's Sio Gene Therapies Inc. Common Stock position peaked at $1.04K in Q4 2022.
4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.

Based on Wolff Wiese Magana's 13F filing for Q1 2023, filed 18 Apr 2023.